Molecular testing practices and perceptions among dermatopathologists.
Kristin TorrePreeti JhorarRong WuJohn PfeiferZendee ElabaMichael J MurphyPublished in: Journal of cutaneous pathology (2018)
Wider adoption of molecular testing in dermatopathology may be limited by factors such as physician training, test costs/insurance coverage, logistical issues and lack of evidence-based clinical practice guidelines. Dermatopathologists have concerns regarding clinical validity/utility and inappropriate/overuse of some molecular tests. The importance of longitudinal education in molecular technologies and their applications for trainee and practicing physicians is highlighted.